8 | PRTO 28% v3,9M c.8352 f22M H.955 | znewcar1 | 01/09/2020 4:59:54 PM |
7 | PRTO 22% v694K c.4401 f22M H | znewcar1 | 12/30/2019 4:40:56 PM |
6 | PRTO 50% v19,7M c.6234 f19M H.71 nice late | znewcar1 | 05/22/2019 11:45:18 PM |
5 | PRTO 50% v19,7M c.6234 f19M H .71 | znewcar1 | 05/22/2019 11:41:10 PM |
4 | PRTO 19% v1,M c.4490 f19M big gap from | znewcar1 | 05/21/2019 12:02:46 AM |
3 | 21.62% v118,077 c2.2500 f19,221,292 sold trading | znewcar1 | 12/28/2018 4:36:21 PM |
2 | $PRTO at resistance $2.50 Nasdaq GM | PoemStone | 06/10/2018 4:35:09 PM |
1 | Gap fill ~100%? idk, I don't see news, there was | znewcar1 | 03/20/2018 9:38:23 PM |
Recent Articles
- Monster Energy Athletes Excel at 2025 UCI Downhill Cup
- Trevi Therapeutics Discusses Promising Phase 2b Study Results
- Explore How Fans Hash is Revolutionizing Crypto Mining Today
- Horizon Petroleum Advances Operations for Production Start
- Blokees Launches Innovative Building Block Toys in Mexico
- SIBIONICS Leads Innovations at the 3rd AGP&DTx Summit
- Viatris Investors: Key Updates on Securities Fraud Action
- Transgene and NEC Showcase Promising Cancer Vaccine Results
- Bicara Therapeutics Reports Promising Cancer Treatment Results
- Turkcell Sets Major Milestone with First Full Duplex 5G Test
- Investigation into Biohaven Ltd. Sparks Investor Concerns
- How to Buy a Car During a Cost-of-Living Crisis
- How To Prepare Your Car for Storage During a Wyoming Winter
- Constellis Enhances Training Solutions for Security Professionals
- Innovative Oncology Navigation Grant Program Announced
- Breakthrough ALLO-316 Data Demonstrates Promise for RCC Therapy
- Investigation Launched for Investors of Amerant Bancorp Inc. AMTB
- Investigation into Arvinas, Inc. Over Securities Fraud Claims
- Investigation of Meta Platforms: Uncovering Recent Concerns
- Innovative AI Assessment Tool Unveils New Avenues for African PR
- How to Future-Proof Your Investment Property
- NeuroPace, Inc. Investors Urged to Seek Legal Guidance Immediately
- Investors on Alert: Class Action Lawsuit Against Napco Soon
- Investing with Confidence: Elevance Health Class Action Updates
- Humana Inc. Facing Investigation Over Securities Fraud Claims
- Understanding UroGen Pharma's Recent Issues and Investor Impact
- Investigation Launched on Behalf of Wabash National Investors
- Understanding Investor Concerns with 3D Systems Corporation
- Investigation of Luminar Technologies: Implications for Investors
- Deepcoin Unveils Innovative Website and App Upgrade for Traders
- Shanghai Hosts Successful Dragon Boat Tournament with Global Teams
- Investing in Yourself: The Role of Education in Entrepreneurial Success
- Transforming Newlywed Life: EKOUAER’s Special Wedding Edition
- Bausch + Lomb Investigated for Securities Fraud Allegations
- FTI Consulting, Inc. Under Investigation: What Investors Should Know
- Novel Insights on RP1 Therapy from Replimune's Recent Study
- Investors Urged to Explore Potential Claims Against Apple
- Coinbase Global, Inc. Faces Investigation Amid Data Breach Concerns
- Understanding Investor Concerns Around Travere Therapeutics Inc.
- Bakkt Holdings Faces Class Action Amid Significant Revenue Loss
- Viatris Inc. Facing Class Action Lawsuit Amid Investor Losses
- Zenas BioPharma Faces Class Action Lawsuit - Key Details
- Investigation into ADTRAN Holdings, Inc. by Pomerantz Law Firm
- Investigation Into Redwire Corporation Raises Concerns
- Key Updates on Open Lending Corporation Class Action Lawsuit
- West Pharmaceutical Services Faces Class Action Over Securities Fraud
- UnitedHealth Group Faces Class Action Amid Stock Drop
- Iovance Biotherapeutics Under Investigation for Possible Fraud
- Understanding the Risks of Investing in DoubleVerify Holdings
- Avis Budget Group Faces Class Action Lawsuit Amid Financial Issues